4//SEC Filing
Conway Kevin John 4
Accession 0002051408-25-000004
CIK 0001733294other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:05 PM ET
Size
9.0 KB
Accession
0002051408-25-000004
Insider Transaction Report
Form 4
Conway Kevin John
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-10-15−58→ 294 total→ Common Stock (58 underlying) - Exercise/Conversion
Common Stock
2025-10-15+58→ 1,885 total - Tax Payment
Common Stock
2025-10-15$6.71/sh−18$121→ 1,867 total
Footnotes (3)
- [F1]Amounts reported in this Form 4 reflect the one-for-10 reverse stock split effected by the issuer on July 21, 2025.
- [F2]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F3]The grant of 939 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0002051408
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:05 PM ET
- Size
- 9.0 KB